Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

BETA-SITOSTEROL CRS (25 MG)

BETA-SITOSTEROL CRS (25 MG)

83-46-5

DISCOVER
IRISFLORENTIN CRS (15 MG)

IRISFLORENTIN CRS (15 MG)

41743-73-1

DISCOVER
KETOTIFEN FOR PEAK IDENTIFICATION CRS (10 MG)

KETOTIFEN FOR PEAK IDENTIFICATION CRS (10 MG)

NA

DISCOVER
LEVONORGESTREL FOR SYSTEM SUITABILITY 2 CRS (10 MG)

LEVONORGESTREL FOR SYSTEM SUITABILITY 2 CRS (10 MG)

797-63-7

DISCOVER
KETOTIFEN HYDROGEN FUMARATE CRS (10 MG)

KETOTIFEN HYDROGEN FUMARATE CRS (10 MG)

34580-14-8

DISCOVER
2,4-DICHLOROBENZYL ALCOHOL CRS (250 MG)

2,4-DICHLOROBENZYL ALCOHOL CRS (250 MG)

1777-82-8

DISCOVER
2,4-DICHLOROBENZYL ALCOHOL IMPURITY A CRS (25 MG)

2,4-DICHLOROBENZYL ALCOHOL IMPURITY A CRS (25 MG)

34145-05-6

DISCOVER
2,4-DICHLOROBENZYL ALCOHOL IMPURITY C CRS (25 MG)

2,4-DICHLOROBENZYL ALCOHOL IMPURITY C CRS (25 MG)

1805-32-9

DISCOVER
HEPATITIS A VACCINE ELISA DETECTION ANTIBODIES SET - BRR (29

HEPATITIS A VACCINE ELISA DETECTION ANTIBODIES SET - BRR (29

NA

DISCOVER
HEPATITIS A VIRUS COATING REAGENT FOR ELISA - BRR (0.5 ML)

HEPATITIS A VIRUS COATING REAGENT FOR ELISA - BRR (0.5 ML)

NA

DISCOVER
SALMETEROL XINAFOATE FOR PEAKIDENTIFICATION CRS (15 MG)

SALMETEROL XINAFOATE FOR PEAKIDENTIFICATION CRS (15 MG)

94749-08-3

DISCOVER
ZIPRASIDONE MESILATE TRIHYDRATE CRS (30 MG)

ZIPRASIDONE MESILATE TRIHYDRATE CRS (30 MG)

199191-69-0

DISCOVER